Aspira Biosystems

Aspira Biosystems, Inc. has developed artificial antibody technology for the production of advanced protein binders and protein capture biochips. The company's products are based on the patent-pending platform technology ProteinPrint™, which enables sequence-based separation and analysis of known and unknown proteins.